Specification :

What is Geftinat ( Iressa or Gefitinib) ?
Geftinat ( gefitinib) by Natco is generic version of Iressa. Geftinat is a cancer chemotherapy medication. Geftinat interferes with the growth of cancer cells and slows their growth and spread in the body. Gefitinib is used in the treatment of non-small cell lung cancer. Iressa tablets contain 250 mg of gefitinib and are available as brown film-coated tablets for daily oral administration

Indications :
Geftinat) is indicated as monotherapy for the continued treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of both platinum-based and docetaxel chemotherapies who are benefiting or have benefited from Gefitinib. Geftinat may also be used for purposes other than those listed in this drug information guide.

Dosage :
The recommended daily dose of Geftinat is one 250 mg tablet with or without food. Higher doses do not give a better response and cause increased toxicity. However, your oncologist may make dose adjustment as per required.

Side Effects :
Serious side effects have been reported with the use of Iressa including: allergic reactions ( difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives) ; lung problems; liver problems; eye problems; severe nausea, vomiting, loss of appetite, or diarrhea; and others.

Overdosage :
Symptoms of a Geftinat overdose tend to be similar to side effects caused by the medication, although often more severe. If you suspect over dose seek emergency medical attention or contact your healthcare provider immediately.

Contraindications :
Geftinat ( Iressa or Gefitinib) is contraindicated in patients with severe hypersensitivity to gefitinib or to any other component of gefitinib.

Specifications

Product Name Geftinat ( IRESSA - Gefitinib)
Contains Gefitinib 250mg
Form Tablet
Strength Available in 250mg
Other Brand Name IRESSA
Packing Pack of 30 tablets 250mg ( Gefitinib Tablets)